• 1. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 2. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 3. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 4. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 5. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977

Recent Advances in the Study of (1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl)methanol (CAS: 1260659-13-9)

The compound (1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl)methanol, with the CAS number 1260659-13-9, has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This molecule, characterized by its trifluoromethyl and pyrazole functional groups, exhibits unique physicochemical properties that make it a promising candidate for various applications, including drug discovery and agrochemical development. Recent studies have focused on its synthesis, biological activity, and potential therapeutic uses, shedding light on its versatility and efficacy.

One of the key areas of research involves the synthesis and optimization of (1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl)methanol. A study published in the Journal of Medicinal Chemistry (2023) detailed a novel, high-yield synthetic route that improves the scalability and purity of the compound. The researchers employed a multi-step process involving the condensation of trifluoromethyl-substituted pyrazole precursors followed by selective oxidation to yield the desired alcohol. This advancement is crucial for large-scale production, which is essential for further pharmacological evaluation.

In terms of biological activity, (1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl)methanol has shown promising results as an intermediate in the development of kinase inhibitors. Kinases are a critical target in oncology, and the trifluoromethyl group in this compound enhances its binding affinity to ATP-binding sites. A recent preclinical study demonstrated that derivatives of this molecule exhibit potent inhibitory effects against several cancer-related kinases, including EGFR and BRAF, with IC50 values in the nanomolar range. These findings suggest its potential as a scaffold for next-generation anticancer agents.

Beyond oncology, this compound has also been explored for its antimicrobial properties. A 2023 study in Bioorganic & Medicinal Chemistry Letters reported that (1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl)methanol derivatives exhibit broad-spectrum activity against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). The mechanism of action appears to involve disruption of bacterial cell wall synthesis, making it a candidate for addressing antibiotic resistance. Further structure-activity relationship (SAR) studies are underway to optimize its efficacy and reduce potential toxicity.

In the agrochemical sector, (1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl)methanol has been investigated as a precursor for novel pesticides. Its trifluoromethyl group contributes to enhanced lipophilicity and metabolic stability, which are desirable traits for agrochemicals. Recent field trials have shown that derivatives of this compound effectively control pests such as aphids and whiteflies, with minimal environmental impact. These results highlight its potential as a sustainable alternative to conventional pesticides.

Despite these promising developments, challenges remain. The metabolic stability and pharmacokinetic profile of (1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl)methanol and its derivatives require further optimization to improve bioavailability and reduce off-target effects. Additionally, the environmental fate of its agrochemical applications needs comprehensive assessment to ensure long-term sustainability. Collaborative efforts between academia and industry are essential to address these challenges and translate these findings into practical applications.

In conclusion, (1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl)methanol (CAS: 1260659-13-9) represents a versatile and valuable compound in chemical biology and pharmaceutical research. Its unique structural features and broad biological activity make it a focal point for ongoing studies in drug discovery, antimicrobial development, and agrochemical innovation. Continued research and development efforts are expected to unlock its full potential, paving the way for novel therapeutic and agricultural solutions.

• 1174308-83-8(5-(Difluoromethyl)-1-methyl-1H-pyrazole-3-carboxylic acid)
• 153085-15-5(1-methyl-5-(trifluoromethyl)pyrazole)
• 1173266-46-0((1-ethyl-3-(trifluoromethyl)-1H-pyrazol-5-yl)methanol)
• 153912-60-8((1,5-Dimethyl-1H-Pyrazol-3-Yl)Methanol)
• 82755-49-5(1,3-dimethyl-5-(trifluoromethyl)-1H-pyrazole)
• 128694-63-3(1-Methyl-3-(trifluoromethyl)-1H-pyrazole-5-carboxylic acid)
• 481065-92-3(1-Methyl-5-(trifluoromethyl)-1H-pyrazole-3-carboxylic acid)
• 949898-58-2((1-methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl)methanol)
• 1446786-29-3(2-[1-methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl]ethan-1-ol)
• 79080-31-2(1,5-Dimethyl-3-(trifluoromethyl)-1H-pyrazole)